U.S. Biotech Industry Analysis
UpdatedJun 04, 2024
DataAggregated Company Financials
Companies573
- 7D0.6%
- 3M-4.9%
- 1Y6.3%
- YTD0.1%
Over the last 7 days, the Biotech industry has remained flat, although notably AbbVie gained 4.4%. As for the the longer term, the industry is up 6.3% over the past 12 months. As for the next few years, earnings are expected to grow by 25% per annum.
Industry Valuation and Performance
Has the U.S. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 05 Jun 2024 | US$1.1t | US$164.6b | -US$26,652,225,135.77 | 27.8x | -42.5x | 6.9x |
| Fri, 03 May 2024 | US$1.1t | US$163.6b | -US$26,775,356,164.78 | 24.8x | -41x | 6.7x |
| Sun, 31 Mar 2024 | US$1.2t | US$164.4b | -US$23,602,941,195.66 | 21.6x | -50x | 7.2x |
| Tue, 27 Feb 2024 | US$1.2t | US$166.9b | -US$21,602,631,007.37 | 13.5x | -55.1x | 7.1x |
| Thu, 25 Jan 2024 | US$1.4t | US$204.7b | -US$22,524,950,232.00 | 18.2x | -63.9x | 7x |
| Sat, 23 Dec 2023 | US$1.4t | US$204.9b | -US$22,145,415,775.00 | 19.4x | -61.9x | 6.7x |
| Mon, 20 Nov 2023 | US$1.2t | US$204.7b | -US$22,041,460,760.00 | 18.1x | -55.3x | 6x |
| Wed, 18 Oct 2023 | US$1.3t | US$207.4b | -US$13,066,450,907.00 | 17.3x | -97.1x | 6.1x |
| Fri, 15 Sep 2023 | US$1.3t | US$207.5b | -US$12,636,400,679.00 | 17.6x | -101.2x | 6.2x |
| Sun, 13 Aug 2023 | US$1.3t | US$207.7b | -US$12,540,100,481.00 | 17.1x | -102.7x | 6.2x |
| Tue, 11 Jul 2023 | US$1.1t | US$186.4b | -US$16,008,439,670.00 | 13.2x | -70x | 6x |
| Thu, 08 Jun 2023 | US$1.1t | US$186.0b | -US$16,014,822,818.00 | 11.7x | -71.2x | 6.1x |
| Sat, 06 May 2023 | US$1.2t | US$192.6b | -US$12,088,374,569.00 | 15.6x | -97.1x | 6.1x |
| Mon, 03 Apr 2023 | US$1.2t | US$217.0b | -US$6,024,358,980.00 | 14.3x | -192.4x | 5.3x |
| Wed, 01 Mar 2023 | US$1.1t | US$199.6b | -US$4,168,872,201.00 | 15.4x | -271.3x | 5.7x |
| Fri, 27 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.8x | 660.1x | 5.7x |
| Sun, 25 Dec 2022 | US$1.2t | US$203.3b | US$1.6b | 14.5x | 703.1x | 5.7x |
| Tue, 22 Nov 2022 | US$1.1t | US$202.1b | US$1.2b | 14.7x | 915.5x | 5.5x |
| Thu, 20 Oct 2022 | US$1.0t | US$206.1b | US$5.4b | 15.6x | 191.2x | 5x |
| Sat, 17 Sep 2022 | US$1.1t | US$206.6b | US$5.8b | 14.7x | 184.5x | 5.2x |
| Mon, 15 Aug 2022 | US$1.1t | US$206.8b | US$7.3b | 15.9x | 154.7x | 5.4x |
| Wed, 13 Jul 2022 | US$1.1t | US$211.3b | US$10.7b | 17.2x | 101.6x | 5.1x |
| Fri, 10 Jun 2022 | US$993.8b | US$212.7b | US$11.2b | 15.5x | 88.5x | 4.7x |
| Sun, 08 May 2022 | US$989.8b | US$207.7b | US$9.7b | 15.5x | 101.8x | 4.8x |
| Tue, 05 Apr 2022 | US$1.3t | US$227.0b | US$14.5b | 18.9x | 90.5x | 5.8x |
| Thu, 03 Mar 2022 | US$1.2t | US$222.6b | US$8.8b | 19.9x | 140.7x | 5.6x |
| Sat, 29 Jan 2022 | US$1.2t | US$212.2b | US$2.5b | 23x | 492x | 5.8x |
| Mon, 27 Dec 2021 | US$1.4t | US$212.0b | US$2.8b | 26.1x | 522.3x | 6.8x |
| Wed, 24 Nov 2021 | US$1.4t | US$211.9b | US$3.2b | 26.4x | 446.8x | 6.8x |
| Fri, 22 Oct 2021 | US$1.5t | US$195.8b | -US$3,119,382,838.00 | 25.1x | -477.1x | 7.6x |
| Sun, 19 Sep 2021 | US$1.6t | US$196.3b | -US$2,228,427,647.00 | 25.6x | -715.8x | 8.1x |
| Tue, 17 Aug 2021 | US$1.6t | US$197.0b | -US$1,662,914,785.58 | 22.8x | -941.6x | 7.9x |
Price to Earnings Ratio
-1810.8x
Current Industry PE
- Investors are optimistic on the American Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 6.2x is lower than the industry's current PS ratio of 6.8x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 5.8% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
| US Market | -0.61% | |
| Healthcare | 0.077% | |
| Biotech | 0.57% | |
| Biotech | 0.57% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ABBV AbbVie | US$162.14 | 4.4% +US$12.0b | 19.7% | PE48.1x | |
| VRTX Vertex Pharmaceuticals | US$474.95 | 6.3% +US$7.2b | 43.7% | PE30.5x | |
| AMGN Amgen | US$307.37 | 2.4% +US$3.9b | 38.9% | PE43.8x | |
| SMMT Summit Therapeutics | US$7.31 | 205.6% +US$3.5b | 268.9% | PB116x | |
| BIIB Biogen | US$234.13 | 7.0% +US$2.2b | -21.9% | PE29.2x |
